Thus, genetic silencing of STAT3 or pharmacological inhibition of its upstream kinases prevents pancreatic cancer cells from gaining integrin β3 expression in response to cytokines or stress in vitro. This evidence concerns the gene STAT3 and familial pancreatic carcinoma.